REFERENCES
1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-49.
2. Surveillance, Epidemiology, and End Results Program. Cancer stat facts: esophageal cancer. https://seer.cancer.gov/statfacts/html/esoph.html. (accessed 2025-02-14).
3. van Hagen P, Hulshof MC, van Lanschot JJ, et al; CROSS Group. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074-84.
4. Shapiro J, van Lanschot JJB, Hulshof MCCM, et al; CROSS study group. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16:1090-8.
5. Mertens AC, Kalff MC, Eshuis WJ, Van Gulik TM, Van Berge Henegouwen MI, Gisbertz SS; Dutch Upper GI Cancer Audit group. Transthoracic versus transhiatal esophagectomy for esophageal cancer: a nationwide propensity score-matched cohort analysis. Ann Surg Oncol. 2021;28:175-83.
6. Khaitan PG, Vekstein AM, Thibault D, et al. Robotic esophagectomy trends and early surgical outcomes: the US experience. Ann Thorac Surg. 2023;115:710-7.
7. Biere SS, van Berge Henegouwen MI, Maas KW, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. 2012;379:1887-92.
8. Straatman J, van der Wielen N, Cuesta MA, et al. Minimally invasive versus open esophageal resection: three-year follow-up of the previously reported randomized controlled trial: the TIME trial. Ann Surg. 2017;266:232-6.
9. van Workum F, Stenstra MHBC, Berkelmans GHK, et al. Learning curve and associated morbidity of minimally invasive esophagectomy: a retrospective multicenter study. Ann Surg. 2019;269:88-94.
10. van der Sluis PC, van der Horst S, May AM, et al. Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: a randomized controlled trial. Ann Surg. 2019;269:621-30.
11. Babic B, Müller DT, Jung JO, et al. Robot-assisted minimally invasive esophagectomy (RAMIE) vs. hybrid minimally invasive esophagectomy: propensity score matched short-term outcome analysis of a European high-volume center. Surg Endosc. 2022;36:7747-55.
12. Fujita T, Sato K, Ozaki A, et al. Propensity-matched analysis of the short-term outcome of robot-assisted minimally invasive esophagectomy versus conventional thoracoscopic esophagectomy in thoracic esophageal cancer. World J Surg. 2022;46:1926-33.
13. Morimoto Y, Kawakubo H, Ishikawa A, et al. Short-term outcomes of robot-assisted minimally invasive esophagectomy with extended lymphadenectomy for esophageal cancer compared with video-assisted minimally invasive esophagectomy: a single-center retrospective study. Asian J Endosc Surg. 2022;15:270-8.
14. Tsunoda S, Obama K, Hisamori S, et al. Lower incidence of postoperative pulmonary complications following robot-assisted minimally invasive esophagectomy for esophageal cancer: propensity score-matched comparison to conventional minimally invasive esophagectomy. Ann Surg Oncol. 2021;28:639-47.
15. Ekeke CN, Kuiper GM, Luketich JD, et al. Comparison of robotic-assisted minimally invasive esophagectomy versus minimally invasive esophagectomy: a propensity-matched study from a single high-volume institution. J Thorac Cardiovasc Surg. 2023;166:374-82.e1.
16. Zhang Y, Dong D, Cao Y, et al. Robotic versus conventional minimally invasive esophagectomy for esophageal cancer: a meta-analysis. Ann Surg. 2023;278:39-50.
17. Angeramo CA, Bras Harriott C, Casas MA, et al. Minimally invasive Ivor Lewis esophagectomy: robot-assisted versus laparoscopic-thoracoscopic technique. Systematic review and meta-analysis. Surgery. 2021;170:1692-701.
18. Huang Y, Zhao YL, Song JD. Early outcomes with robot-assisted vs. minimally invasive esophagectomy for esophageal cancer: a systematic review and meta-analysis of matched studies. Eur Rev Med Pharmacol Sci. 2021;25:7887-97.
19. Zhou J, Xu J, Chen L, et al. McKeown esophagectomy: robot-assisted versus conventional minimally invasive technique-systematic review and meta-analysis. Dis Esophagus. 2022;35:doac011.
20. Weijs TJ, Ruurda JP, Luyer MDP, et al. New insights into the surgical anatomy of the esophagus. J Thorac Dis. 2017;9:S675-80.
21. Hoelzen JP, Fortmann L, Roy D, et al. Robotic-assisted esophagectomy with total mesoesophageal excision enhances R0-resection in patients with esophageal cancer: a single-center experience. Surgery. 2024;176:721-9.
22. Kang CH, Yun TY, Park JH, et al. Long-term survival analysis of robotic esophagectomy for esophageal cancer. Dis Esophagus. 2024;37:doae054.
23. Byiringiro I, Aurit SJ, Nandipati KC. Long-term survival outcomes associated with robotic-assisted minimally invasive esophagectomy (RAMIE) for esophageal cancer. Surg Endosc. 2023;37:4018-27.
24. Kingma BF, Grimminger PP, van der Sluis PC, et al; UGIRA Study Group. Worldwide techniques and outcomes in robot-assisted minimally invasive esophagectomy (RAMIE): results from the multicenter international registry. Ann Surg. 2022;276:e386-92.
25. Yang Y, Li B, Yi J, et al. Robot-assisted versus conventional minimally invasive esophagectomy for resectable esophageal squamous cell carcinoma: early results of a multicenter randomized controlled trial: the RAMIE trial. Ann Surg. 2022;275:646-53.
26. Chao YK, Li ZG, Wen YW, et al. Robotic-assisted esophagectomy vs video-assisted thoracoscopic esophagectomy (REVATE): study protocol for a randomized controlled trial. Trials. 2019;20:346.
27. Chao YK, Li ZG, Wen YW, et al. 552. Comparing robotic esophagectomy to video-assisted thoracoscopic esophagectomy for esophageal squamous cell carcinoma: results from the REVATE randomized clinical trial. Dis Esophagus. 2024;37:doae057.278.
28. Tagkalos E, van der Sluis PC, Berlth F, et al. Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial). BMC Cancer. 2021;21:1060.
29. Klotz R, Diener MK, Schmidt T, et al. Overall morbidity after total minimally invasive keyhole oesophagectomy versus hybrid oesophagectomy (the MICkey trial): study protocol for a multicentre randomized controlled trial. Trials. 2023;24:175.
30. National Library of Medicine. RAE versus MIE in patients with esophageal cancer after neoadjuvant therapy. https://clinicaltrials.gov/study/NCT06012214?term=esophagectomy&limit=100&intr=Robotic&rank=3#publications. (accessed 2025-02-14).
31. National Library of Medicine. ClinicalTrials.Gov. https://clinicaltrials.gov/. (accessed 2025-02-14).
32. Knitter S, Maurer MM, Winter A, et al. Robotic-assisted Ivor Lewis esophagectomy is safe and cost equivalent compared to minimally invasive esophagectomy in a tertiary referral center. Cancers. 2023;16:112.
33. Goense L, van der Sluis PC, van der Horst S, et al. Cost analysis of robot-assisted versus open transthoracic esophagectomy for resectable esophageal cancer. Results of the ROBOT randomized clinical trial. Eur J Surg Oncol. 2023;49:106968.
34. Liu F, Yang W, Yang W, et al. Minimally invasive or open esophagectomy for treatment of resectable esophageal squamous cell carcinoma? Answer from a real-world multicenter study. Ann Surg. 2023;277:e777-84.
